• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Cretex Companies CEO Steps Down

    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

    Endoscopic Hemostasis Devices Market Valued at $730 Million

    Henry Schein Buys Majority Interest in Prism Medical Products

    Boston Scientific's Vercise Genus DBS Earns FDA Approval
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    K-Tube Technologies

    Spectrum Plastics Group

    MW Life Sciences

    Unicep
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    PTI Engineered Plastics Inc.

    K-Tube Technologies

    Creganna Medical, part of TE Connectivity

    Medbio LLC

    Unicep
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Buyer (and Seller) Beware: Rate-Setting Commissions and the Future of Healthcare Delivery

    ...

    Related CONTENT
    • CHF Solutions Appoints CEO
    • CMS Expedites Breakthrough Device Access; Industry Applauds
    • New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    • FOREFRONT MEDICAL TECHNOLOGY ANNOUNCES UNIQUELY-DESIGNED COVID-19 TEST SWAB
    • Finding the Upside to a Challenging Year
    Jeffrey J. Kimbell and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc.06.04.18
    As the fierce healthcare debate of repeal-and-replace has tapered off in the nation’s swamp, states are using their authority to craft innovative policy solutions to improve the health and well-being of their populations that reflect the politics of each state. While increasing access to life-changing medical technologies certainly aligns with the goals of creating a healthier population, not all states seem to agree on exactly how to get there. One concerning bill is being debated in California: Assembly Bill (AB) 3087, introduced Feb. 16 by Democratic Assemblymen Ash Kalra and Mark Stone. AB-3087 emerged from a California legislature that is eager to achieve universal healthcare coverage without passing legislation to create a highly controversial, and exceedingly expensive, single payer entity in the state. The result is a cost containment proposal that neither achieves more coverage nor improves health outcomes.

    The bill would create the California Healthcare Cost, Quality, and Equity Commission, an independent state agency designed to control in-state healthcare costs and set the amounts accepted as payment by hospitals, physicians, physician groups, and other healthcare providers for items and services, including medical devices for commercially insured residents. One key purpose of the Commission is to determine ways for the California state government to reduce the cost of medical devices paid for by private purchasers in the commercial market.

    Lawmakers liken AB-3087 to Maryland’s popular all-payer model, but this is a disingenuous claim. The Maryland system is one in which the state sets payment rates for hospital services for all payers, with the intent that individual hospitals will receive the same payment amount for the same services to streamline reimbursement and lessen the effects of inadequate third-party payment. In California, however, AB-3087 would require the Commission to annually determine the base amounts that healthcare entities are required to accept as full payment for healthcare services, where the base amount for an entity shall be no lower than 100 percent of Medicare rates. The problem is that Medicare pays roughly 77 cents for every private healthcare dollar in California, resulting in a 23 percent payment decrease for healthcare entities if the Commission chooses to enact the maximum statutory cut—a cut which will surely be felt by manufacturers who contract with such entities. Furthermore, Medicare rates are set at the federal level by the Centers for Medicare and Medicaid Services (CMS), and there can be positive or negative variation in payment rates due to political and economic interests. By tying payments in the state commercial market to a federal program, AB-3087 subjects healthcare providers to the whims of Congress, not what is best for their California patients.

    Proponents of AB-3087 also tout how the bill would create an appeals process for the Commission to reconsider payment adjustments, such as if the costs of a medical technology were substantially more expensive than the payment rate set by the Commission. Essentially, this appeals process would force doctors, hospitals, and other providers to beg for more equitable payments from the Commission to be able to deliver necessary, high-quality care, including innovative medical technologies, to Californians. Under this bill, doctors would lose valuable time by having to ask permission from a government-run Commission to practice medicine as they see fit.

    On its face, AB-3087 also excludes the ability for critical stakeholder input. The Commission created by AB-3087 would include 11 paid members and not a single member of the Commission, nor staff of the Commission, can be employed by or be a consultant to medical technology companies and manufacturers. Doctors, hospitals, trial lawyers, economists, and consumer advocates, however, are eligible to be appointed to the Commission. Fundamentally, the Commission created by AB-3087 gives government bureaucrats and a select group of non-elected stakeholders enormous control over healthcare decision-making in the state.

    This issue is as timely as it is important. At the time of writing this article, AB-3087 is waiting to be considered by the California State Assembly Committee on Appropriations. Even if this bill is defeated in this session, by the Committee on Appropriations or in the California State Senate, it will absolutely be resurrected in 2019. In fact, Gavin Newsom, the front-runner in the California governor’s race, has emphatically campaigned on the need for state-run, universal healthcare in California. AB-3087 is a logical extension of and further commitment to government-run healthcare. This concept has been considered at the national level as well. For example, on May 9, U.S. Representative Rosa DeLauro (D-CT) introduced a bill to create a price review board at the Department of Health and Human Services (HHS) that would regulate pharmaceutical and medical device prices.

    AB-3087 would have a devastating impact on the California healthcare industry. According to initial estimates by the California Medical Association (CMA), AB-3087 would cause roughly 175,000 hospital workers alone to lose their jobs and force many hospitals and medical practices to close. AB-3087 would also push physicians, dentists, and other clinicians into early retirement or to other states that have more viable working conditions. It should be no surprise that numerous influential stakeholders in the medical and healthcare communities are leading the opposition to the bill. Ardent supporters of the bill can overlook these troublesome statistics, yet neither of the bill’s co-sponsors has been able to refute the economic claims or offer solutions to mitigate them.

    If this bill were to pass, medical technology manufacturers would not only be forced to accept a government-mandated price for their products in a way that circumvents established business practices in the private market, but manufacturers would also see their sales significantly drop, as there would be fewer healthcare entities and purchasers in the market. This bill would significantly disrupt the supply chain, and in the end, patients would ultimately suffer.

    Many well-respected health policy experts have conducted analyses to show the clinical and economic benefits of adopting medical technologies, including the California-based Milken Institute. In their Healthy Savings (2014) report on the value of medical technology, the Milken Institute estimates that the net annual benefit from using medical technology is more than $23 billion per year based on medical technologies’ abilities to detect, manage, or cure certain medical conditions, such as colorectal cancer and heart disease. Additionally, federal income tax revenue can be increased by over $7 billion each year due to improved labor market outcomes of a healthier population.

    Furthermore, the medical technology industry plays a key role in the robust life sciences sector in California. In total, the life science industry in California employs almost 300,000 people and brings in approximately $150 billion in revenue per year. As a result, employees in this industry earn over $116,000 per year on average. The state attracts over $4.4 billion in investments from venture capitalists and the National Institutes of Health (NIH), among others. Indirectly, the life sciences industry generates over 600,000 other jobs in the state as well, employing software engineers, consultants, contractors, communications professionals, and intellectual property attorneys. The California life sciences industry is booming—creating high-wage jobs for its employees, bringing new therapies and technologies to patients, and securing significant funding for future medical advancements.

    California is home to manufacturers that produce many life-saving technologies, such as surgical devices and equipment, neurological and cardiac devices, and diabetes care management supplies. Why would the California State Assembly want to take up a bill against the economic interest and health of their state and constituents? AB-3087 puts a scary political agenda ahead of economic reality. The bill would put a promising future of medical technology innovation in jeopardy by stifling companies’ potential revenues, which is a vital component of the innovation lifecycle’s longevity. Instead, California legislators should be doing everything they can to help the sector grow and to continue creating life-changing medical technologies. Perhaps the best way to do this is to exclude the medical technology sector from this overly burdensome legislation altogether and instead allow the market to set prices. A stronger, more competitive economy, not government intervention, will facilitate business transactions among medical technology manufacturers and other stakeholders so new innovations are reaching patients as quickly as possible.

    The Commission proposed by AB-3087 is eerily similar to the now-repealed—and vehemently industry and physician opposed—Independent Payment Advisory Board (IPAB). IPAB was a gross government overreach created under the Patient Protection and Affordable Care Act intended to cut healthcare costs by reducing Medicare payments with little Congressional oversight or accountability. There were widespread concerns from many stakeholders that IPAB, an unelected advisory board of bureaucrats, could exert too much power over the doctor-patient relationship in the Medicare program. Ultimately, due to broad bipartisan consensus that the power given to the cost-containment board was severely misplaced, IPAB was repealed. If history serves as any guide of what is to come, the California legislature should remind itself of the simple fact that Americans do not like the looming threat of government intervention in their personal lives or healthcare decisions.

    The clinical, economic, and societal value of innovative medical technologies is clear, particularly in the state of California. AB-3087 would not continue the legacy of medical advancements in California, but rather dismantle it and set the healthcare system on an irreversible path. When the medical technology sector suffers, patients suffer as a result. AB-3087 must not pass the California legislature. 

    June 7 legislative update: AB-3087 failed to advance from the California State Assembly Appropriations Committee, which officially blocks the bill from becoming law during this legislative session. The bill’s co-author, Assemblyman Ash Kalra, asked Appropriations Chairwoman Lorena Gonzalez Fletcher to pull his bill from consideration, and stated, "At my request, holding the bill in the Assembly Appropriations Committee will allow for more dialogue and engagement, and for the health care industry to come to the table and not continue to delay or ignore the issue." Expect a new and improved cost containment bill to return in 2019, along with questions about ways California's health care sector might change once a new governor is elected.


    Jeffrey J. Kimbell, president and founder of Jeffrey J. Kimbell & Associates, Inc., represents over 35 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the firm provides strategic solutions to hand-selected clients seeking creation, modification, or proper implementation of public law.

    Caroline P. Tucker is a manager of health policy and reimbursement strategy at Jeffrey J. Kimbell & Associates, Inc. She graduated with a B.A. in the history of science and medicine from the Johns Hopkins University and with an M.S. in health policy from the Milken Institute School of Public Health at the George Washington University. 
    Related Searches
    • cardiac
    • quality
    • diabetes
    • technology
    Suggested For You
    CHF Solutions Appoints CEO CHF Solutions Appoints CEO
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    FOREFRONT MEDICAL TECHNOLOGY ANNOUNCES UNIQUELY-DESIGNED COVID-19 TEST SWAB FOREFRONT MEDICAL TECHNOLOGY ANNOUNCES UNIQUELY-DESIGNED COVID-19 TEST SWAB
    Finding the Upside to a Challenging Year Finding the Upside to a Challenging Year
    First Patient Enrolled in NovaSignal First Patient Enrolled in NovaSignal's Intelligent Ultrasound Clinical Trial
    Avail Medsystems Raises $100 Million in Series B Funding Avail Medsystems Raises $100 Million in Series B Funding
    Mentice to Acquire Vascular Simulations Mentice to Acquire Vascular Simulations
    Medtronic Launches InPen with Real-Time Guardian Connect CGM Data Medtronic Launches InPen with Real-Time Guardian Connect CGM Data
    Alucent Biomedical Closes $35 Million Series B Financing Round Alucent Biomedical Closes $35 Million Series B Financing Round
    Veteran Medical Device Executives Named to Dimension Inx Board  Veteran Medical Device Executives Named to Dimension Inx Board
    Harvard Professor Joins ExThera Medical Board Harvard Professor Joins ExThera Medical Board
    The Lost Year: 2020 Year in Review The Lost Year: 2020 Year in Review
    Digital Health Delivers During a Year for the Ages Digital Health Delivers During a Year for the Ages
    The Top 30 and M&A in 2021: What’s Next? The Top 30 and M&A in 2021: What’s Next?

    Related Columns

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20


    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20

    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20


    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20

    • COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      Having been a part of the medtech supply chain for 40 years, I can say there has never been a more difficult time for supply chain professionals.
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Next Life Medical; CEO, Emergent Respiratory 11.04.20

    • Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

      The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle.
      Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc. 11.04.20


    • 3D/Additive Manufacturing
      Additive Manufacturing: Debinding Fluids Must-Haves

      Additive Manufacturing: Debinding Fluids Must-Haves

      As the pressure to produce more complex biomedical parts increases, medical device manufacturing using 3D printing is gaining widespread acceptance.
      Venesia Hurtubise, Technical Chemist, MicroCare Medical 11.04.20

    • Diagnostics
       How COVID-19 is Reshaping the Diagnostics Testing Sector

      How COVID-19 is Reshaping the Diagnostics Testing Sector

      The short-term impact on the diagnostics sector is readily apparent as the pandemic has fueled overwhelming demand for effective SARS-CoV-2 testing solutions.
      Eric Williams, Managing Director, Capstone Headwaters 11.04.20

    • Will Industry’s COVID-19 Recovery End Prematurely?

      Will Industry’s COVID-19 Recovery End Prematurely?

      Finally, a light at the end of the tunnel, but will it remain lit?
      Michael Barbella, Managing Editor 10.01.20


    • Surgical
      Hype or Hope? The Future of Surgical Robotics

      Hype or Hope? The Future of Surgical Robotics

      Recent publications suggest the U.S. performs more robotic surgery than every other country in the world.
      Maria Shepherd, President and Founder, Medi-Vantage 10.01.20

    • COVID Community: How the Pandemic Is Bringing Out the Best in Us

      COVID Community: How the Pandemic Is Bringing Out the Best in Us

      Given the brain power and generosity of our industry, I knew I could follow the wisdom of Fred Rogers’ mother and “look for the helpers.”
      Dawn A. Lissy, Founder & President, Empirical 10.01.20

    • Electronics
      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      When looking to outsource the manufacture of electronic medical devices, cleanliness standards and processes should be a top consideration.
      Jay Tourigny, Senior Vice President, MicroCare Medical 10.01.20


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • TPI Partners With Zeiss
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Understanding Food-Grade Vs. Biocompatibility For Medical Device Materials
    Breaking News
    • Cretex Companies CEO Steps Down
    • Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    • Endoscopic Hemostasis Devices Market Valued at $730 Million
    • Henry Schein Buys Majority Interest in Prism Medical Products
    • Boston Scientific's Vercise Genus DBS Earns FDA Approval
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login